Patrick Lefebvre, MA

Hospitalizations, Emergency Room Visits and Adherence Among Patients With Schizophrenia Initiated on Long-Acting Injectable Versus Oral Antipsychotics: A Systematic Review and Meta-Analysis

Long-acting injectable (LAI) antipsychotics, compared with oral antipsychotics (OA), have the potential to increase medication adherence in adult patients with schizophrenia. This increas...

Maria-Helene Lafeuille , MA;

Philippe Thomas-Leduc , MSc;

Isabelle Ghelerter ;

Patrick Lefebvre , MA;

Ha Nguyen , BA;

Dee Lin , PharmD, MS;

Panagiotis Mavros , PhD;

Carmella Benson , MSc, MS, MSHP;

10/08/2020

Real-World Treatment Persistence Among Advanced Therapy-Experienced Patients With Ulcerative Colitis Initiated on Ustekinumab or Adalimumab

1 Analysis Group Inc., Montréal, Quebec, Canada; 2 Janssen Scientific Affairs, LLC., Horsham, Pennsylvania, United States.

Maryia Zhdanava , MA;

Sumesh Kachroo ;

Porpong Boonmak ;

Sabree Burbage ;

Aditi Shah , MA;

Jill Korsiak ;

Patrick Lefebvre , MA;

Caroline Kerner ;

Dominic Pilon , MA;

01/11/2024

Medication Adherence, Healthcare Resource Utilization, and Costs Among Medicaid Beneficiaries With Schizophrenia Treated With Once-monthly Paliperidone Palmitate or Once-every-three-months Paliperidone Palmitate

Background: Antipsychotics with reduced dosing frequency may improve adherence and clinical outcomes for patients with schizophrenia. This study compared adherence, persistence, healthcar...

Maryia Zhdanava , MA;

Maria-Helene Lafeuille , MA;

Kruti Joshi , MPH, MD;

Patrick Lefebvre , MA;

Dominic Pilon , MA;

Dee Lin , PharmD, MS;

Aurelie Cote ;

Maude Vermette-Laforme , BSc;

10/08/2020

Comparison of Real-World Healthcare Resource Utilization Among Advanced Therapy-Experienced Patients With Ulcerative Colitis Initiated on Ustekinumab or Vedolizumab

1 Analysis Group Inc., Montréal, Quebec, Canada; 2 Janssen Scientific Affairs, LLC., Horsham, Pennsylvania, United States.

Aditi Shah , MA;

Jill Korsiak ;

Patrick Lefebvre , MA;

Caroline Kerner ;

Dominic Pilon , MA;

Maryia Zhdanava , MA;

Sumesh Kachroo ;

Porpong Boonmak ;

Sabree Burbage ;

01/11/2024

Cluster Analysis of Care Pathways in Major Depressive Disorder With Suicidal Ideation or Probable Suicide Attempt

BACKGROUND: To understand heterogeneity among the population with major depressive disorder (MDD) and suicidal ideation (SI) or attempt (SA) (MDD+SI/SA), clusters were identified through ...

Laura Morrison , MPH;

Maryia Zhdanava , MA;

Patrick Lefebvre , MA;

Dominic Pilon , MA;

Kruti Joshi , MPH, MD;

Cheryl Neslusan , PhD;

Tom Cornwall , PhD;

Maude Vermette-Laforme , BSc;

Abigail Nash , MD, PhD;

10/08/2020

Treatment Persistence Among Anti-TNF-Experienced Patients With Ulcerative Colitis Switching to Ustekinumab or Cycling to Another Anti-TNF Agent

1 Analysis Group Inc., Montréal, Quebec, Canada; 2 Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, United States.

Maryia Zhdanava , MA;

Sumesh Kachroo ;

Porpong Boonmak ;

Sabree Burbage ;

Aditi Shah , MA;

Patrick Lefebvre , MA;

Dominic Pilon , MA;

Bridget Godwin ;

01/11/2024

Characteristics of Commercially Insured Patients Initiated on Esketamine Nasal Spray in a Real-World Setting

BACKGROUND: Esketamine nasal spray was approved for adults with treatment-resistant depression on 03/05/2019. Real-world data on patients initiated on esketamine is limited. METHODS: Adu...

Laura Morrison , MPH;

Swapna Karkare , MS;

Abigail Nash , MD, PhD;

Maryia Zhdanava , MA;

Aditi Shah , MA;

Patrick Lefebvre , MA;

Dominic Pilon , MA;

Kruti Joshi , MPH, MD;

10/08/2020

Risk of Subsequent Relapses and Corresponding Healthcare Costs Among Recently-Relapsed Medicaid Patients With Schizophrenia

BACKGROUND: Schizophrenia relapses can cause a significant increase in healthcare resource utilization and costs. However, the risk of relapse may be different between patients initiated ...

Edward S. Kim , MD, FACP, MBA;

Patrick Lefebvre , MA;

Dee Lin , PharmD, MS;

Kruti Joshi , MPH, MD;

Bruno Emond , MA;

Charmi Patel , BS , RN, BSN, MPH;

Laura Morrison , MPH;

Maria-Helene Lafeuille , MA;

11/22/2019

Economic Burden of Treatment Resistant Depression in Privately Insured US Patients With Behavioral Comorbidities

BACKGROUND: Incremental economic burden of treatment resistant depression (TRD) in patients with behavioral comorbidities is largely unknown.

Craig Nelson , MD;

Carmine Rossi , PhD;

Ella Daly , MB, BCh, BAO;

Maryia Zhdanava , MA;

Harsh Kuvadia ;

Patrick Lefebvre , MA;

Dominic Pilon , MA;

Kruti Joshi , MPH, MD;

11/22/2019

Prevalence, Incidence and Economic Burden of Schizophrenia Among Medicaid Beneficiaries

Background: Schizophrenia carries a substantial economic burden to healthcare systems and payers. This study aims to update the prevalence, incidence and economic burden of schizophrenia ...

Charmi Patel , BS , RN, BSN, MPH;

Maryia Zhdanava , MA;

Maria-Helene Lafeuille , MA;

Patrick Lefebvre , MA;

Aurélie Côté-Sergent , MSc;

Dominic Pilon , MA;

Dee Lin , PharmD, MS;

Kruti Joshi , MPH, MD;

11/22/2019